The WACC of Chenguang Biotech Group Co Ltd (300138.SZ) is 7.8%.
Range | Selected | |
Cost of equity | 8.8% - 12.9% | 10.85% |
Tax rate | 12.6% - 13.8% | 13.2% |
Cost of debt | 5.0% - 5.0% | 5% |
WACC | 6.7% - 8.9% | 7.8% |
Category | Low | High |
Long-term bond rate | 2.7% | 3.2% |
Equity market risk premium | 6.1% | 7.1% |
Adjusted beta | 1.01 | 1.29 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 8.8% | 12.9% |
Tax rate | 12.6% | 13.8% |
Debt/Equity ratio | 0.88 | 0.88 |
Cost of debt | 5.0% | 5.0% |
After-tax WACC | 6.7% | 8.9% |
Selected WACC | 7.8% | |
Debt/Equity | Unlevered | |||
Peers | Company Name | ratio | Beta | beta |
300138.SZ | Chenguang Biotech Group Co Ltd | 0.88 | 1.36 | 0.77 |
000848.SZ | He Bei Cheng De LoLo Co Ltd | 0.02 | 0.88 | 0.87 |
000911.SZ | Nanning Sugar Industry Co Ltd | 1.24 | 0.68 | 0.33 |
002570.SZ | Beingmate Co Ltd | 0.2 | 1.13 | 0.96 |
002661.SZ | Kemen Noodle Manufacturing Co Ltd | 0.76 | 0.99 | 0.6 |
1230.HK | Yashili International Holdings Ltd | 0.11 | 0.07 | 0.07 |
600127.SS | Jinjian Cereals Industry Co Ltd | 0.16 | 0.61 | 0.53 |
600300.SS | V V Food & Beverage Co Ltd | 0.04 | 1.13 | 1.1 |
603711.SS | Xiangpiaopiao Food Co Ltd | 0.13 | 1.62 | 1.46 |
9977.HK | Shandong Fengxiang Co Ltd | 0.34 | 0.61 | 0.47 |
Low | High | |
Unlevered beta | 0.57 | 0.81 |
Relevered beta | 1.01 | 1.43 |
Adjusted relevered beta | 1.01 | 1.29 |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for 300138.SZ:
cost_of_equity (10.85%) = risk_free_rate (2.95%) + equity_risk_premium (6.60%) * adjusted_beta (1.01) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.